Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |